You are using an older browser version. Please use a supported version for the best MSN experience.

BRIEF-Avrobio Announces Updated Clinical Data From Ongoing Phase 1 And Phase 2 Studies For AVR-RD-01 Gene Therapy

Reuters logo Reuters 2/6/2019

Feb 6 (Reuters) - AVROBIO Inc:

* AVROBIO, INC. ANNOUNCES UPDATED CLINICAL DATA FROM ONGOING PHASE 1 AND PHASE 2 STUDIES FOR AVR-RD-01 GENE THERAPY FOR FABRY DISEASE

* AVROBIO INC - AVR-RD-01 HAS BEEN GENERALLY WELL TOLERATED IN PHASE 1 AND PHASE 2 STUDIES TO DATE

* AVROBIO - NO SERIOUS ADVERSE EVENTS ASSESSED RELATED TO AVR-RD-01 WERE REPORTED AS OF SAFETY DATA CUT-OFF DATES FOR PHASE 2 STUDY AND PHASE 1 STUDY Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

AdChoices
AdChoices

More From Reuters

image beaconimage beaconimage beacon